Imatinib Withdrawn Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) / Chronic Myeloid Leukemia, Blast Crisis Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00594555A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia